BioGeneration Ventures

Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

Therapeutics for obesity and obesity-related conditions.

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

Brenig Therapeutics develops therapies for neurodegenerative disorders.

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.